Michael L Lunn

Summary

Affiliation: Pennsylvania State University
Country: USA

Publications

  1. pmc Ecallantide for the treatment of hereditary angiodema in adults
    Michael Lunn
    Penn State Hershey Section of Allergy and Immunology, Hershey, PA 17033, USA
    Clin Med Insights Cardiol 5:49-54. 2011
  2. pmc Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
    Michael Lunn
    Penn State Hershey Section of Allergy, Asthma and Immunology, Hershey, PA USA
    J Blood Med 1:163-70. 2010
  3. doi Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
    Michael L Lunn
    Division of Pulmonary, Allergy, and Critical Care Medicine, Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania 17033, USA
    Ann Allergy Asthma Immunol 104:211-4. 2010
  4. ncbi Rhinitis and sleep
    Michael Lunn
    Penn State Hershey Medical Center, MSHMC UPC HO41, Division of Pulmonary, Critical Care, and Allergy Immunology, 500 University Drive, Hershey, PA 17033 0850, USA
    Sleep Med Rev 15:293-9. 2011

Collaborators

Detail Information

Publications4

  1. pmc Ecallantide for the treatment of hereditary angiodema in adults
    Michael Lunn
    Penn State Hershey Section of Allergy and Immunology, Hershey, PA 17033, USA
    Clin Med Insights Cardiol 5:49-54. 2011
    ..Although there is a small risk for anaphylaxis, which limits home administration, ecallantide is a novel, safe, effective and alternative treatment for acute HAE attacks...
  2. pmc Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
    Michael Lunn
    Penn State Hershey Section of Allergy, Asthma and Immunology, Hershey, PA USA
    J Blood Med 1:163-70. 2010
    ....
  3. doi Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
    Michael L Lunn
    Division of Pulmonary, Allergy, and Critical Care Medicine, Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania 17033, USA
    Ann Allergy Asthma Immunol 104:211-4. 2010
    ....
  4. ncbi Rhinitis and sleep
    Michael Lunn
    Penn State Hershey Medical Center, MSHMC UPC HO41, Division of Pulmonary, Critical Care, and Allergy Immunology, 500 University Drive, Hershey, PA 17033 0850, USA
    Sleep Med Rev 15:293-9. 2011
    ..It explores the adverse effects of disturbed sleep on patients' quality of life and how these disturbances can be reduced by therapies that address nasal congestion...